WASTE MANAGEMENT INC Q1 FY2025 earnings call

Management Statement and Operational Highlights

• Jim Fish: Highlighted strong Q1 results, >12% growth in operating EBITDA, contributions from Healthcare Solutions and sustainability. Confident in achieving guidance, focus on customer lifetime value, technology, sustainability, and acquisitions.
• John Morris: Operating overview of collection and disposal business, volume and yield details, operating costs and margin improvements, retention and automation investments, confidence in full-year targets.
• Devina Rankin: Financial details, legacy business margin 30% for 4th consecutive quarter, cash flow and capital expenditure details, free cash flow on plan, share buybacks paused, expected solid waste acquisitions in 2025, leverage outlook.

Segment Performance

• Total Company: Operating EBITDA grew >12% in Q1 2025 vs Q1 2024, driven by collection/disposal, WM Healthcare Solutions, and sustainability.
• Sustainability Businesses: Combined operating EBITDA from recycling and renewable energy grew >20% Y/Y. Automated recycling facilities had nearly double the operating EBITDA margin vs non-automated. Added 2 new facilities in CA and TX, with 7 next-gen recycling plants scheduled in 2025. Renewable energy grew from new RNG plants and strong pricing, with 8 additional RNG facilities under construction.
• Collection and Disposal Business: Q1 operating EBITDA up almost 5%, margin expanded 10 bps. Revenue grew from 4% yield and 6.5% core price. Volumes flat on workday-adjusted basis, but special waste pipelines strong. Operating expenses 60.5% of revenue, 40 bps improvement Y/Y. Residential line of business operating EBITDA margin grew >130 bps to 20% for first time in 6 years.
• WM Healthcare Solutions: Integration progress, new customers excited by environmental expertise, on track to achieve $250M annual run rate synergies by 2027.

Guidance

• Total company operating EBITDA guidance: $7.45B - $7.65B.
• Free cash flow guidance: $2.675B - $2.775B.
• Sustainability businesses on track to meet full-year targets.
• Healthcare Solutions on track to achieve $250M annual run rate synergies by 2027.
• Expect >$500M of solid waste acquisitions in 2025.

Risks

• Tariffs and trade negotiations could impact sustainability investments, but WM is well-positioned.
• Labor market challenges, including aging and shrinking workforce, impact on operations.
• Economic uncertainties and potential impacts on volume and pricing.
• Regulatory changes, such as EPA releases on PFOS, could affect the industry.

Question and Answer Q: Bryan Burgmeier asks about 2Q outlook and margin improvement for solid waste.

A: Devina Rankin responds on seasonality, margin expansion drivers.

Q: Kevin Chiang asks about yield in solid waste business.

A: John Morris comments on yield trends and margin focus.

Q: Kevin Chiang asks about Stericycle revenue trends and shedding of businesses.

A: Rafael Carrasco discusses revenue performance and synergy capture.

Q: Tyler Brown asks about RNG and recycling EBITDA targets.

A: Tara Hemmer and Devina Rankin talk about performance and tariff impacts.

Q: Trevor Romeo asks about M&A and Healthcare Solutions customer feedback.

A: Devina Rankin and John Morris discuss M&A pipeline and customer anecdotes.

Q: Sabahat Khan asks about residential margins and Stericycle synergies.

A: John Morris and Devina Rankin talk about residential margins and Stericycle synergy timing.

Q: Toni Kaplan asks about resilience and fleet impacts of tariffs.

A: Jim Fish and John Morris discuss industry resilience and fleet positioning.

Q: Noah Kaye asks about PFOS and Stericycle synergies.

A: Devina Rankin and John Morris talk about PFOS and Stericycle synergy details.

Q: Konark Gupta asks about Stericycle margin and SG&A.

A: Devina Rankin explains margin gaps and long-term value creation.

Q: Tobey Sommer asks about Stericycle learnings and international divestitures.

A: Jim Fish and Rafael Carrasco discuss Stericycle learnings and international strategy.

Q: Jerry Revich asks about legacy business costs and RIN pricing.

A: Tara Hemmer talks about RIN pricing and volume monetization.

Q: David Manthey asks about tariffs and OCC pricing.

A: Devina Rankin and Jim Fish discuss tariff impacts on OCC.

Q: James Schumm asks about Stericycle SG&A and long-term outlook.

A: Devina Rankin and Jim Fish talk about Stericycle SG&A targets and long-term growth.

Q: Stephanie Moore asks about labor force and technology.

A: John Morris discusses labor reduction efforts and technology investments.